Allergy Doctor Dallas Texas – Dr. Barbara Baxter
Youtube Link: http://youtu.be/lRiMo9j7Zyc
Tag: asthma treatment
Sinusitis is characterized by inflammation and swelling of the sinuses (the air-filled cavities around the nasal passages). Some of the symptoms include:
- Nasal congestion
- Thick nasal discharge
- Post-nasal drip
- Facial pressure or pain (especially behind the eyes)
- Difficulty in smelling
- Cough
- Soar Throat
- Headache
If you are experiencing any of these symptoms, you should consult Dr. Baxter to talk about diagnosis and treatment options. #sinus #allergist #asthmatreatment #allergies #dallas
Board Certified in Internal Medicine and Allergy-Immunology, Dr. Barbara Baxter, an allergy doctor Dallas TX practices in North Dallas.
Dr. Baxter is a member of Genesis Physicians Group, the American Medical Association, the Texas Medical Association, the Dallas County Medical Society and the Texas Allergy, Asthma and Immunology Society.
We offer the following services:
- Allergy skin testing for inhalant, food and insect sensitivities
- Patch testing for contact dermatitis
- Penicillin skin testing
- Allergy immunotherapy injections and clusters of injections
- Evaluation of the immune system for people with recurrent or unusual infections
- Pulmonary function testing including exhaled nitric oxide measurements
- Infusion therapy for humoral immune deficiencies
- Xolair injections (anti-IqE) for severe asthma
- Seasonal flu shots (September to May)
- Pnuemovax (pneumonia vaccine)
- Tetanus/Diphtheria/Pertussis for adults
- TB test
- Microscopic exam of nasal secretions and sputum
- Blood tests
- Tympanometry
- Cultures, when indicated; immediate Strep assays
- Nebulizer treatments for asthma
- Measurement of blood oxygen saturation (pulse Oximetry)
- Methacholine challenge test
- A comprehensive weight loss and maintenance program in partnership with Ideal Protein
- Counseling for select patients including hypnosis and regression
- Opportunities to participate in clinical trials of new medications for a broad variety of conditions through Discovery Clinical Trials partnership.
- The opportunity to experience energy healing through a method called reiki.
Vitamin D supplementation has no significant effect on the overall rate of first treatment failure or exacerbation in patients with asthma and low vitamin D levels, according to the Vitamin D Add-on Therapy Enhances Corticosteroid Responsiveness in Asthma (VIDA) trial.
However, in subjects who reached normal vitamin D levels, there were significant reductions in exacerbations and the rate of first treatment failure.
Retrospective studies have linked serum 25-hydroxyvitamin D levels below 30 ng/mL to airway hyper-responsiveness, impaired lung function, increased exacerbation frequency, and reduced corticosteroid responsiveness. It has also been suggested that vitamin D enhances the anti-inflammatory effect of corticosteroids.
Dr. Castro and colleagues evaluated 408 adults with symptomatic asthma and a serum 25-hydroxyvitamin D level below 30 ng/mL at 9 medical centers in the United States that belong to AsthmaNet, the National Heart, Lung, and Blood Institute asthma network.
Patients were randomized to receive an initial dose of 100,000 IU of oral vitamin D₃ followed by 4000 IU/day for 28 weeks (n = 201) or placebo (n = 207). At 28 weeks, there was a significant difference in cumulative ciclesonide dosing between the vitamin D and placebo groups (111.3 vs 126.2 µg/day; P = .02).
In addition, “the overall asthma treatment failure was significantly reduced and the exacerbations were significantly reduced in subjects that got to a normal vitamin D level,” said Dr. Castro reported.
Dr. Castro’s “gut feeling” is that vitamin D supplementation will prove to be useful in at least some people with asthma who have low vitamin D. He said he plans to study exacerbations in children who achieve sufficient vitamin D levels.
COURTESY: MEDSCAPE – For the latest medical news, clinical trial coverage, drug updates, journal articles, CME activities & more!
Read the full article at: http://www.medscape.com/viewarticle/825444?src=emailthis
